About Harbin Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Harbin Clinic
During the past decade, Harbin Clinic conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 15 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Harbin Clinic" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Smith & Nephew, Inc." with 3 trials
sponsored, "Sunovion" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "AnGes USA, Inc."
with 1 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Harbin Clinic"
#1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Global Research Solutions" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Harbin Clinic
According to Clinical.Site data, the most researched conditions in "Harbin Clinic" are
"Rheumatoid Arthritis" (3 trials), "Acute Gout" (2 trials), "Atherosclerosis" (2 trials), "Coronary Artery Disease" (2 trials) and "Rotator Cuff Injuries" (2 trials). Many other conditions were trialed in "Harbin Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Harbin Clinic
Most popular intervention types in "Harbin Clinic" are "Drug" (16 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Abemaciclib" (2 trials), "Eslicarbazepine acetate" (2 trials), "Infliximab" (2 trials) and "1200 mg QD Eslicarbazepine acetate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Harbin Clinic
The vast majority of trials in "Harbin Clinic" are
24 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Harbin Clinic
Currently, there are NaN active trials in "Harbin Clinic".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Harbin Clinic,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Harbin Clinic, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Harbin Clinic
Harbin Clinic has several departments that took part in Clinical trials: "Harbin Clinic Medical Oncology and Clinical Research" - 72 trials, "Regional Radiation Oncology Center at Rome" - 28 trials, "Harbin Clinic Southeastern Cardiovascular Institute" - 2 trials, "Harbin Clinic Orthopaedics & Sports Medicine Rome" - 2 trials